Fibromyalgia(fm) is a syndrome characterized by a chronic widespread musculoskeletal pain, fatigue, poor sleep, paresthesias, headache, irritable bowel syndrome, and other comorbid problems multitude of associated symptoms. The condition is described as primarily affecting middle-aged women. Fm has no known cause or cure, and it seems that a multidisciplinary approach to treatment is necessary to meet the complex needs of this patients. We have created, a multidisciplinary program that involves a cooperative effort among the departments of Neurology, Psichiatry, Immunology and Reumatology, and Physical Rehabilitation (University of Naples "Federico II")to support the patients. After three primary visits the diagnosis is effected and we proposed to the patient the possible treatment pharmacological, psychotherapy or both, to follow. After treatment psychic symptoms significantly improved.
The gol of the project is improve the management of depression in the primary care setting. In first time we meet the primary care physicians for a consensus conference on depression, clinical case and the treatment recommendations in the primary care setting. In second time we sent the guidelines to all contracted primary care physicians and specialists via the practitioner newsletter. The guidelines were developed in conjunction with the SIMG (società Italiana di Medicina Generale), and the S.I.P. (Società Italiana di Psichiatria) and Department of Mental Health. The guidelines included treatment of major depressive disorder. In the third time the health plan continues to periodically update the guidelines and provide them to all practitioners.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.